NCT02090335 Health Promotion and Fitness for Younger and Older Adults With SMI Status COMPLETED Phase NA
NCT02088060 A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients Status TERMINATED Phase PHASE2
NCT02087579 Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants Status COMPLETED Phase PHASE1
NCT02086786 Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia Status COMPLETED Phase PHASE2
NCT02086162 Randomized Controlled Trial (RCT) of a Motivational Decision Support System Status COMPLETED Phase NA
NCT02085447 A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness Status COMPLETED Phase NA
NCT02079844 Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia Status COMPLETED Phase PHASE1
NCT02077829 Implementation of Illness Management and Recovery in Mental Health Services Status COMPLETED Phase NA
NCT02075528 Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER Status COMPLETED Phase PHASE4
NCT02074319 RCT of Methotrexate Added to Treatment As Usual in Schizophrenia Status COMPLETED Phase PHASE1
NCT02069925 STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S. Status COMPLETED Phase NA
NCT02069392 Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia Status COMPLETED Phase NA
NCT02067975 Tryptophan MRI in People With Schizophrenia and Healthy Controls Status COMPLETED Phase PHASE2/PHASE3
NCT02062190 Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT02055287 Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT02054702 Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia Status COMPLETED Phase PHASE3
NCT02051387 Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study Status COMPLETED Phase PHASE1
NCT02050854 Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia Status COMPLETED Phase N/A